tiprankstipranks
Endonovo Therapeutics (ENDV)
OTHER OTC:ENDV
US Market
ENDV
Endonovo Therapeutics
RESEARCH TOOLSreports
Want to see ENDV full AI Analyst Report?

Endonovo Therapeutics (ENDV) Financial Statements

24 Followers

Endonovo Therapeutics Financial Overview

Endonovo Therapeutics's market cap is currently $180.76K. The company's EPS TTM is $; its P/E ratio is -0.06; Endonovo Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 0.00$ 10.04K$ 140.24K$ 135.35K$ 73.11K
Gross Profit$ 0.00$ -615.20K$ -514.51K$ 125.36K$ 58.12K
Operating Income$ -945.77K$ -1.56M$ -2.92M$ -3.26M$ -2.23M
EBITDA$ -945.77K$ -941.40K$ 8.85M$ -16.51M$ -1.51M
Net Income$ -2.18M$ -2.80M$ 6.92M$ -18.47M$ -3.10M
Balance Sheet
Cash & Short-Term Investments$ 12.00$ 3.00$ 1.84K$ 98.00$ 85.94K
Total Assets$ 19.30K$ 19.29K$ 639.66K$ 1.28M$ 2.01M
Total Debt$ 6.91M$ 6.87M$ 7.07M$ 7.15M$ 7.18M
Net Debt$ 6.91M$ 6.87M$ 7.07M$ 7.15M$ 7.10M
Total Liabilities$ 28.89M$ 26.82M$ 24.75M$ 33.46M$ 17.78M
Stockholders' Equity$ -28.87M$ -26.80M$ -24.11M$ -32.18M$ -15.77M
Cash Flow
Free Cash Flow$ -42.99K$ 100.49K$ 121.87K$ -678.84K$ -986.58K
Operating Cash Flow$ -42.99K$ 100.49K$ 121.87K$ -678.84K$ -986.58K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 43.00K$ -105.33K$ -120.13K$ 593.00K$ 1.06M
Currency in USD

Endonovo Therapeutics Earnings and Revenue History

Income Statement >

Endonovo Therapeutics Debt to Assets

Balance Sheet >

Endonovo Therapeutics Cash Flow

Cash Flow >

Endonovo Therapeutics Forecast EPS vs Actual EPS

Earnings >